dc.contributor.author
Gruen, Arne
dc.contributor.author
Exner, Sebastian
dc.contributor.author
Kühl, Jörn-Sven
dc.contributor.author
Stackelberg, Arend von
dc.contributor.author
Budach, Volker
dc.contributor.author
Stromberger, Carmen
dc.contributor.author
Boehmer, Dirk
dc.date.accessioned
2023-07-19T12:47:31Z
dc.date.available
2023-07-19T12:47:31Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/40174
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-39895
dc.description.abstract
Background: Total body irradiation (TBI) is an established part of conditioning regimens prior to stem cell transplantation in childhood leukemia but is associated with long-term toxicity. We retrospectively analyzed survival, long-term toxicity, and secondary malignancies in a pooled cohort of pediatric patients (pts.) treated with the same TBI regimen.
Methods: Analyzed were 109 pts. treated between September 1996 and November 2015. Conditioning treatment according to EBMT guidelines and the ALL SCTped 2012 FORUM trial consisted of chemotherapy (CT) and TBI with 2 Gy b.i.d. on 3 consecutive days to a total dose of 12 Gy. Median follow-up was 97.9 months (2-228 months).
Results: Overall survival (OS) in our cohort at 2, 5, and 10 years was 86.1, 75.5, and 63.0%, respectively. Median survival was not reached. Long-term toxicity developed in 47 pts. After chronically abnormal liver and kidney parameters in 31 and 7 pts., respectively, growth retardation was the most frequent finding as seen in 13 pts. Secondary malignancies were rare (n = 3).
Conclusion: TBI-containing conditioning regimens in pediatric stem cell transplantation (SCT) are highly effective. Efforts to replace TBI- with CT-containing regimens have only been successful in subgroups of pts. Although we could show long-term toxicity in 43% of pts., overall survival was 63% at 10 years. Still, long-term effects such as growth retardation can permanently impact the pts.' quality of life and functioning. Along with new substances, efforts should be undertaken to optimize TBI techniques and accompany the treatment by systematic follow-up programs beyond 5 years to improve detection of rare events.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Late adverse events
en
dc.subject
Radiation induced cancer
en
dc.subject
Cancer of the blood
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Total body irradiation as part of conditioning regimens in childhood leukemia—long-term outcome, toxicity, and secondary malignancies
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.1007/s00066-021-01810-4
dcterms.bibliographicCitation.journaltitle
Strahlentherapie und Onkologie
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.pagestart
33
dcterms.bibliographicCitation.pageend
38
dcterms.bibliographicCitation.volume
198
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34282476
dcterms.isPartOf.issn
0179-7158
dcterms.isPartOf.eissn
1439-099X